BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 17517971)

  • 21. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
    Lehtinen MJ; Rops AL; Isenman DE; van der Vlag J; Jokiranta TS
    J Biol Chem; 2009 Jun; 284(23):15650-8. PubMed ID: 19351878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.
    Hyvärinen S; Uchida K; Varjosalo M; Jokela R; Jokiranta TS
    J Biol Chem; 2014 Feb; 289(7):4295-306. PubMed ID: 24344133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: report of a case.
    Gnappi E; Allinovi M; Vaglio A; Bresin E; Sorosina A; Pilato FP; Allegri L; Manenti L
    Pediatr Nephrol; 2012 Oct; 27(10):1995-9. PubMed ID: 22669321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare genetic variant in the CFB gene presenting as atypical hemolytic uremic syndrome and immune complex diffuse membranoproliferative glomerulonephritis, with crescents, successfully treated with eculizumab.
    Alfakeeh K; Azar M; Alfadhel M; Abdullah AM; Aloudah N; Alsaad KO
    Pediatr Nephrol; 2017 May; 32(5):885-891. PubMed ID: 28210841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance.
    Tortajada A; Pinto S; Martínez-Ara J; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
    Kidney Int; 2012 Jan; 81(1):56-63. PubMed ID: 21881555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E; Rurali E; Caprioli J; Sanchez-Corral P; Fremeaux-Bacchi V; Rodriguez de Cordoba S; Pinto S; Goodship TH; Alberti M; Ribes D; Valoti E; Remuzzi G; Noris M;
    J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.
    Saunders RE; Goodship TH; Zipfel PF; Perkins SJ
    Hum Mutat; 2006 Jan; 27(1):21-30. PubMed ID: 16281287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.
    Ståhl AL; Vaziri-Sani F; Heinen S; Kristoffersson AC; Gydell KH; Raafat R; Gutierrez A; Beringer O; Zipfel PF; Karpman D
    Blood; 2008 Jun; 111(11):5307-15. PubMed ID: 18268093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele
    Pouw RB; Gómez Delgado I; López Lera A; Rodríguez de Córdoba S; Wouters D; Kuijpers TW; Sánchez-Corral P
    Front Immunol; 2018; 9():848. PubMed ID: 29740447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
    J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spectrum of phenotypes caused by variants in the CFH gene.
    Boon CJ; van de Kar NC; Klevering BJ; Keunen JE; Cremers FP; Klaver CC; Hoyng CB; Daha MR; den Hollander AI
    Mol Immunol; 2009 May; 46(8-9):1573-94. PubMed ID: 19297022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
    Józsi M; Strobel S; Dahse HM; Liu WS; Hoyer PF; Oppermann M; Skerka C; Zipfel PF
    Blood; 2007 Sep; 110(5):1516-8. PubMed ID: 17495132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
    Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete functional characterization of disease-associated genetic variants in the complement factor H gene.
    Merinero HM; García SP; García-Fernández J; Arjona E; Tortajada A; Rodríguez de Córdoba S
    Kidney Int; 2018 Feb; 93(2):470-481. PubMed ID: 28941939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A haplotype in CFH family genes confers high risk of rare glomerular nephropathies.
    Ding Y; Zhao W; Zhang T; Qiang H; Lu J; Su X; Wen S; Xu F; Zhang M; Zhang H; Zeng C; Liu Z; Chen H
    Sci Rep; 2017 Jul; 7(1):6004. PubMed ID: 28729648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.
    Roumenina LT; Frimat M; Miller EC; Provot F; Dragon-Durey MA; Bordereau P; Bigot S; Hue C; Satchell SC; Mathieson PW; Mousson C; Noel C; Sautes-Fridman C; Halbwachs-Mecarelli L; Atkinson JP; Lionet A; Fremeaux-Bacchi V
    Blood; 2012 May; 119(18):4182-91. PubMed ID: 22246034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of complement in physiology and pathology].
    Klaska I; Nowak JZ
    Postepy Hig Med Dosw (Online); 2007; 61():167-77. PubMed ID: 17410057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS).
    Roumenina LT; Roquigny R; Blanc C; Poulain N; Ngo S; Dragon-Durey MA; Frémeaux-Bacchi V
    Methods Mol Biol; 2014; 1100():237-47. PubMed ID: 24218264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A user's guide to the interactive Web database of factor H-associated hemolytic uremic syndrome.
    Saunders RE; Perkins SJ
    Semin Thromb Hemost; 2006 Mar; 32(2):160-8. PubMed ID: 16575691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.